Saxena A - Search Results

1

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.

Chen Z, Moyana T, Saxena A, Warrington R, Jia Z, Xiang J. Chen Z, et al. Among authors: saxena a. Int J Cancer. 2001 Aug 15;93(4):539-48. doi: 10.1002/ijc.1365. Int J Cancer. 2001. PMID: 11477558

2

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors.

Liu Y, Huang H, Saxena A, Xiang J. Liu Y, et al. Among authors: saxena a. Cancer Gene Ther. 2002 Jun;9(6):533-42. doi: 10.1038/sj.cgt.7700466. Cancer Gene Ther. 2002. PMID: 12032664

3

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J. Chen Z, et al. Among authors: saxena a. Cancer Gene Ther. 2002 Sep;9(9):778-86. doi: 10.1038/sj.cgt.7700498. Cancer Gene Ther. 2002. PMID: 12189528

4

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity.

Liu Y, Zhang W, Chan T, Saxena A, Xiang J. Liu Y, et al. Among authors: saxena a. Leuk Res. 2002 Aug;26(8):757-63. doi: 10.1016/s0145-2126(02)00002-4. Leuk Res. 2002. PMID: 12191571

5

Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.

Liu Y, Saxena A, Zheng C, Carlsen S, Xiang J. Liu Y, et al. Among authors: saxena a. J Gene Med. 2004 Aug;6(8):857-68. doi: 10.1002/jgm.576. J Gene Med. 2004. PMID: 15293344

6

Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro-metastasis.

Chen Z, Xia D, Bi X, Saxena A, Sidhu N, El-Gayed A, Xiang J. Chen Z, et al. Among authors: saxena a. J Gene Med. 2005 Apr;7(4):506-17. doi: 10.1002/jgm.692. J Gene Med. 2005. PMID: 15580588

7

Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression.

Saxena A, Moshynska OV, Moshynskyy ID, Neuls ED, Qureshi T, Bosch M, Voralia M, Bonham K. Saxena A, et al. Cancer Lett. 2007 Jun 18;251(1):114-31. doi: 10.1016/j.canlet.2006.11.007. Epub 2007 Jan 2. Cancer Lett. 2007. PMID: 17198743

8

Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.

Chan T, Chen Z, Hao S, Xu S, Yuan J, Saxena A, Qureshi M, Zheng C, Xiang J. Chan T, et al. Among authors: saxena a. Cancer Gene Ther. 2007 Apr;14(4):409-20. doi: 10.1038/sj.cgt.7701025. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235354

9

Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation.

Chamberlain MD, Chan T, Oberg JC, Hawrysh AD, James KM, Saxena A, Xiang J, Anderson DH. Chamberlain MD, et al. Among authors: saxena a. J Biol Chem. 2008 Jun 6;283(23):15861-8. doi: 10.1074/jbc.M800941200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387942 Free PMC article.

10

Association of a novel single nucleotide polymorphism, G(-248)A, in the 5'-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance.

Saxena A, Moshynska O, Sankaran K, Viswanathan S, Sheridan DP. Saxena A, et al. Cancer Lett. 2002 Dec 10;187(1-2):199-205. doi: 10.1016/s0304-3835(02)00378-6. Cancer Lett. 2002. PMID: 12359369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,811 results

Search Page

Filters